Lighthouse Investment Partners’s Roivant Sciences ROIV Stock Holding History

Lighthouse Investment Partners’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,997	Closed	-$222K	–	919
2026 Q1	$222K	Buy	+7,997	New	+$205K	0.01%	635
2023 Q4	–	Sell	-172,397	Closed	-$2.01M	–	407
2023 Q3	$2.01M	Buy	+172,397	New	+$1.95M	0.08%	235

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Lighthouse Investment Partners's ROIV Position: Q2 2026 in Review

Lighthouse Investment Partners sold out of Roivant Sciences (ROIV) in Q2 2026, closing a stake of 7,997 shares — an estimated $222K sold.

Lighthouse Investment Partners first reported a position in ROIV in Q3 2023 and held it in 2 quarters. The position peaked at $2.01M in Q3 2023. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Lighthouse Investment Partners reported no remaining Roivant Sciences position as of Q2 2026 after selling out during the quarter.
Lighthouse Investment Partners sold 7,997 Roivant Sciences shares in Q2 2026, an estimated $222K.
Lighthouse Investment Partners first reported a position in Roivant Sciences in Q3 2023 and held it in 2 quarters.
Lighthouse Investment Partners's Roivant Sciences position peaked at $2.01M in Q3 2023.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Lighthouse Investment Partners's 13F filing for Q2 2026, filed 14 Aug 2026.